Literature DB >> 17224451

Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation.

Tsuyoshi Morita1, Taira Mayanagi, Toshiyuki Yoshio, Kenji Sobue.   

Abstract

Podosomes are dynamic cell adhesion structures that degrade the extracellular matrix, permitting extracellular matrix remodeling. Accumulating evidence suggests that actin and its associated proteins play a crucial role in podosome dynamics. Caldesmon is localized to the podosomes, and its expression is down-regulated in transformed and cancer cells. Here we studied the regulatory mode of caldesmon in podosome formation in Rous sarcoma virus-transformed fibroblasts. Exogenous expression analyses revealed that caldesmon represses podosome formation triggered by the N-WASP-Arp2/3 pathway. Conversely, depletion of caldesmon by RNA interference induces numerous small-sized podosomes with high dynamics. Caldesmon competes with the Arp2/3 complex for actin binding and thereby inhibits podosome formation. p21-activated kinases (PAK)1 and 2 are also repressors of podosome formation via phosphorylation of caldesmon. Consequently, phosphorylation of caldesmon by PAK1/2 enhances this regulatory mode of caldesmon. Taken together, we conclude that in Rous sarcoma virus-transformed cells, changes in the balance between PAK1/2-regulated caldesmon and the Arp2/3 complex govern the formation of podosomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17224451     DOI: 10.1074/jbc.M609983200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells.

Authors:  Alan S Mak
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

Review 2.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

3.  Polymerization of actin does not regulate desensitization in human basophils.

Authors:  Donald MacGlashan; Natalia Vilariño
Journal:  J Leukoc Biol       Date:  2009-01-15       Impact factor: 4.962

4.  Histochemical localization of caldesmon in the CNS and ganglia of the mouse.

Authors:  Christoph N Köhler
Journal:  J Histochem Cytochem       Date:  2011-03-16       Impact factor: 2.479

5.  Fascin1 promotes cell migration of mature dendritic cells.

Authors:  Yoshihiko Yamakita; Fumio Matsumura; Michael W Lipscomb; Po-chien Chou; Guy Werlen; Janis K Burkhardt; Shigeko Yamashiro
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

Review 6.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

7.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

8.  Effect of l-caldesmon on osteoclastogenesis in RANKL-induced RAW264.7 cells.

Authors:  Ying-Ming Liou; Chu-Lung Chan; Renjian Huang; Chih-Lueh A Wang
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

9.  The actin-binding protein caldesmon is in spleen and lymph nodes predominately expressed by smooth-muscle cells, reticular cells, and follicular dendritic cells.

Authors:  Christoph N Köhler
Journal:  J Histochem Cytochem       Date:  2010-02       Impact factor: 2.479

Review 10.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.